Abdominal Aortic Aneurysm Repair System Receives FDA Approval
The FDA has granted premarket approval to Bolton Medical for the TREO Abdominal Stent-Graft System, which is used for endovascular repair of abdominal aortic aneurysms below the renal arteries. Consisting of a stent graft and a delivery catheter, TREO diverts blood flow away from an aneurysm, potentially impeding further enlargement and preventing rupture.
The TREO stent graft is extremely versatile, featuring thousands of configurations that allow it to conform to each patient’s unique aortic anatomy, according to the manufacturer. Two levels of fixation promote stability, and a special locking technology guards against disconnection of stent graft components. Ninety-three percent of patients who received TREO as part of a 150-person clinical study experienced no complications related to the device or aneurysm up to one year after placement.
MedWand Remote Diagnostic Device Honored by CES
MedWand, a handheld device that allows consumers to gather diagnostic data at home to enrich telemedicine appointments, received two awards for innovation in advance of CES, the annual Las Vegas showcase of the latest consumer electronics. Developed by MedWand Solutions Inc., MedWand received CES 2020 Innovation Awards in the “Health and Wellness” and “Tech for a Better World” categories for exceptional design and engineering.
MedWand helps overcome an inherent limitation of telemedicine — healthcare providers’ inability to collect key diagnostic data face to face — by facilitating a remote physical exam. Using the computer mouse-sized device, patients can listen to the heart, lungs and abdomen, examine the ears, eyes, skin and throat, and check temperature and pulse and respiratory rate, among other diagnostic actions. FDA approval for MedWand is pending.
Researchers Develop a Sterilizable, Reusable, Aerosol-Filtrating Mask
In response to the shortage of respiratory personal protective equipment for healthcare workers caused by the COVID-19 pandemic, a group of researchers from Brigham and Women’s Hospital and MIT developed a prototype mask that can be sterilized in an autoclave and reused as an alternative to single-use N95 masks. Known as the Injection Molded Autoclavable, Scalable, Conformable (iMASC) system, the mask is made by injecting liquid silicone rubber into a mold and features two replaceable filters.
In a feasibility study, 20 healthcare workers fit tested the iMASC system and, on average, provided favorable ratings on fit, breathability and ease of filter replacement. The study demonstrated that the mask could fit faces of varying size and shape. Additional testing is ongoing.